Shares of Aptose Biosciences Inc. (TSE:APS – Get Free Report) (NASDAQ:APTO) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of C$0.54 and traded as low as C$0.30. Aptose Biosciences shares last traded at C$0.31, with a volume of 5,500 shares traded.
Aptose Biosciences Stock Down 1.6 %
The company has a market cap of C$5.43 million, a P/E ratio of -0.05 and a beta of 1.36. The company has a debt-to-equity ratio of 670.80, a current ratio of 0.80 and a quick ratio of 5.41. The company has a 50 day moving average of C$0.33 and a 200-day moving average of C$0.54.
About Aptose Biosciences
Aptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies.
Read More
- Five stocks we like better than Aptose Biosciences
- Stock Analyst Ratings and Canadian Analyst Ratings
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- How to Most Effectively Use the MarketBeat Earnings Screener
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- Basic Materials Stocks Investing
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for Aptose Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptose Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
